Menstrual Products
Cross-source consensus on Menstrual Products from 1 sources and 6 claims.
1 sources · 6 claims
Benefits
Preparation
Risks & contraindications
Evidence quality
Other
Highlighted claims
- Scientific evidence on how menstrual products affect the vaginal microbiome remains limited. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Trial participants receive free menstrual products for six cycles, including a menstrual cup usable after the study. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- A woman is described as using an average of 10,000 pads and 15,000 tampons during her lifetime. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Prior Isala evidence associated menstrual pad use with bacteria linked to bacterial vaginosis. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Prior Isala evidence correlated tampon and cup use with a more protective microbial profile. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Monthly kits provide swabs, menstrual products, pH strips, and instructions so participants do not have to arrange their own supplies. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland